Showing results (1-10 of 12) with videos related to
Sort By:
Pageof 2
Journal of the Neurological Sciences|October 3, 2015
LRP1B deletion is associated with poor outcome for glioblastoma patientsE Tabouret, M Labussière, A Alentorn, et al.Progress in Neuro-Psychopharmacology & Biological Psychiatry|April 8, 2009
Pelvic dyskinesia with an outstanding response to tetrabenazineA Alentorn, A Palasí, J Campdelacreu, et al.Revue Neurologique|October 22, 2013
[Nutritional status in patients with recurrent glioblastoma]D Gokcek, J-D Tran, A Gonzalez-Aguilar, et al.Revue Neurologique|November 6, 2022
CSF biomarkers in primary CNS lymphomaL Nguyen-Them, A Alentorn, G Ahle, et al.Revue Neurologique|April 12, 2023
Recent advances in the diagnosis and the treatment of primary CNS lymphomaA Rachdi, H Hernandez-Tost, D Herzi, et al.Journal of Neuro-Oncology|November 17, 2017
Long-term impact of temozolomide on 1p/19q-codeleted low-grade glioma growth kineticsC Izquierdo, A Alentorn, A Idbaih, et al.CPT: Pharmacometrics & Systems Pharmacology|February 24, 2016
Prediction of Response to Temozolomide in Low-Grade Glioma Patients Based on Tumor Size Dynamics and Genetic CharacteristicsP Mazzocco, C Barthélémy, G Kaloshi, et al.Journal of Neuro-Oncology|August 20, 2013
Ongoing and prolonged response in adult low-grade gliomas treated with radiotherapyF Ducray, G Kaloshi, C Houillier, et al.European Journal of Cancer (Oxford, England : 1990)|March 17, 2024
Prognosis of glioblastoma patients improves significantly over time interrogating historical controlsA Thomas-Joulié, S Tran, L El Houari, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 3, 2023
Prediction of response to immune checkpoint blockade in patients with metastatic colorectal cancer with microsatellite instabilityT Ratovomanana, R Nicolle, R Cohen, et al.Pageof 2